Abstract
Background Vitamin D status may be associated with depression, but there have been inconsistencies in the reported estimates. This study aimed to examine the association of vitamin D status with depression in a large general population sample.
Methods Cross-sectional data for a representative Korean sample of 1,825 people aged 19 years or older were obtained from the nationally representative Korean National Health and Nutrition Examination Survey (2014). Depression was defined by Patient Health Questionnaire-9 (PHQ-9) scores ≥10 (moderate/severe). Logistic regression was used to estimate the associations between depression and serum 25-hydroxyvitamin D [25(OH)D] levels. Continuous serum 25(OH)D level was categorized into quartiles. Continuous PHQ-9 scores were assessed using quantile regression. Adjustments for age, sex, marital status, level of education, lowest income quartile, body mass index, level of physical activity, chronic conditions, serum creatinine level, glomerular filtration rate, and history of depression were used in the statistical analyses. Estimates of prevalence and odds ratios (OR) with 95% confidence intervals (CI) were made. Sampling weights were utilized to account for survey design effects.
Results Individuals in the lowest serum 25(OH)D quartile level had significantly higher prevalence of depression than in the upper three quartiles (8.3% vs. 5.1%; p=0.024). No association was observed between serum 25(OH)D level and depression after adjusting for potential covariates (OR 1.48, 95%CI 0.93, 2.35; p=0.097]. However, a stronger association was observed among male respondents, with an estimated OR of 2.54 (95% CI 1.17, 5.50; p=0.018). Additionally, in the quantile regression analysis, estimates from adjusted models remained significant (β = −0.056, p=0.002).
Conclusion While our findings support the association between lower vitamin D status and depression in Korean adults, additional studies are needed to clarify this relationship.
Competing Interest Statement
RWL has received ad hoc speaking/consulting fees or research grants from: Allergan, Asia-Pacific Economic Cooperation, BC Leading Edge Foundation, Canadian Institutes of Health Research (CIHR), Canadian Network for Mood and Anxiety Treatments (CANMAT), Canadian Psychiatric Association, Hansoh, Healthy Minds Canada, Janssen, Lundbeck, Lundbeck Institute, MITACS, Ontario Brain Institute, Otsuka, Pfizer, St. Jude Medical, University Health Network Foundation, and VGH-UBCH Foundation. SBP is supported by the Cuthbertson and Fischer Chair in Pediatric Mental Health. LNY has been on speaker/advisory boards for, or has received research grants from Alkermes, AstraZeneca, Bristol Myers Squibb, CANMAT, CIHR, DSP, Eli Lilly, GlaxoSmithKline, Janssen, Michael Smith Foundation for Health Research, Pfizer, Servier, Sunovion, and Stanley Foundation. YEJ and AKD have no disclosures.
Funding Statement
The authors received no financial support for the research, authorship and/or publication of this article.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not required as data came from a publicly available dataset.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data came from a publicly available dataset as per the manuscript details.
